@article{1191,
  keywords = {Biomedical Research, Black or African American, Cell Line, GWAS, Genetic Variation, HeLa, Humans, Pharmacogenomic Testing, Precision Medicine, White People, ancestry, cell lines, diversity, Drug Discovery, pharmacogenomics, Precision Medicine},
  author = {Sophie Zaaijer and Amanda Capes-Davis},
  title = {Ancestry matters: Building inclusivity into preclinical study design},
  abstract = {Human cell lines (CLs) are key assets for biomedicine but lack ancestral diversity. Here, we explore why genetic diversity among cell-based models is essential for making preclinical research more equitable and widely translatable. We lay out practical actions that can be taken to improve inclusivity in study design.},
  year = {2021},
  journal = {Cell},
  volume = {184},
  pages = {2525-2531},
  month = {2021-05-13},
  issn = {1097-4172},
  doi = {10.1016/j.cell.2021.03.041},
  language = {eng},
}